William J Nahm

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Acute Myeloid Leukemia

Silver Nanoparticles

Basal Cell Carcinoma

Top Venues

Dermatology and therapy

The American journal of case reports

Journal of cutaneous pathology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. Dermatology and therapy 14 (4) (2024)
William J Nahm, Sydney E Liang, Roger S Ho
The immunogenicity of hepatitis B vaccine in psoriasis patients and by treatment type: A retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. Dermatology and therapy 14 (4) (2024)
William J Nahm, Michelle Juarez, Maher Abdul-Hay, Ahan Bhatt, Shane A Meehan, Marianna Shvartsbeyn
Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. The American journal of case reports 25 (2024)
William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. Dermatology and therapy 14 (4) (2024)
William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. Dermatology and therapy 14 (4) (2024)
William J Nahm, Michelle Juarez, Maher Abdul-Hay, Ahan Bhatt, Shane A Meehan, Marianna Shvartsbeyn
Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. The American journal of case reports 25 (2024)
William J Nahm, Michelle Juarez, Maher Abdul-Hay, Ahan Bhatt, Shane A Meehan, Marianna Shvartsbeyn
Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. The American journal of case reports 25 (2024)
William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. Dermatology and therapy (2024)
William J Nahm, Michelle Juarez, Maher Abdul-Hay, Ahan Bhatt, Shane A Meehan, Marianna Shvartsbeyn
Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. The American journal of case reports 25 (2024)
William J Nahm, Gail de Imus, Christopher A Mathe, Liliana Saap, Saiyan Joseph, Stanley Chen, Vincent Falanga
A case of markedly impaired wound repair with angiostatic pazopanib in a patient who had Mohs surgery for a basal cell carcinoma. SAGE open medical case reports 11 (2023)
William J Nahm, Michelle C Juarez, Julie H Wu, Randie H Kim
Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine. Journal of cutaneous pathology (2022)
William J Nahm, Jeenal Gordhandas, Brian Hinds
Atypical Presentation of Transcranial Extension of Intracranial Meningiomas. The American Journal of dermatopathology 44 (3) (2022)
William J Nahm, Kelsey Waite, Therese Recidoro, Luke Lowell, Zechariah C Harris, Nicholas Mendoza, Carlos Vega, Elan Harris, Gerardo Hizon
Treatment of chronic musculoskeletal pain with electron modulation procedure. Pain management 11 (4) (2021)
William J Nahm, Eran C Gwillim, Evangelos V Badiavas, Anna J Nichols, Robert S Kirsner, Laurence H Boggeln, John T Shen
Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin. Dermatology and therapy 11 (1) (2021)
William J Nahm, Andrea Schreck, Jaideep Prasad, Eli Rapoport, Jesus Fragoso, Carlos Vega
Dicyclohexylcarbodiimide commonly causes contact dermatitis but can also be acutely tissue cytotoxic. Contact dermatitis (2021)